In a head-to-head trial, telemedicine-based neurologist assessments in mobile stroke units is safer and more ...

When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he ...

In the wake of the Boulder attack, a neurologist discusses rising political violence in America — and how the cycle stops.

A new algorithm, tested via computer modeling across the continental United States, more accurately routes patients with ...

Some patients with a rare form of ALS benefited from an experimental therapy, with biomarker evidence of reduced injury to neurons and even limited functional recovery.

Data from 12 patients – all treated with a novel therapy for a rare form of ALS caused by a genetic mutation in a gene called ...

Pediatric neurologist Dr. Sonam Kothari is redefining inclusive education in India through BLISS—a K-12 school model that ...

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for nerve dysfunction in your limbs,” says Eva Feldman, a professor of neurology at ...

A new study is questioning the existence of “an alleged ‘mystery’ neurological illness” that emerged in New Brunswick six years ago. The research, published Wednesday in JAMA Neurology, took another ...

Treatment with an experimental drug has shown significant improvements in young patients with a rare form of Amyotrophic ...

An experimental drug known as ulefnersen has shown remarkable efficacy in treating a rare, aggressive form of ALS ...

Researchers say a full-scale clinical trial of the therapy could help many patients with a particularly aggressive form of ...